Skip to main content

$0.053 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
18 May 2025 at 8:35am
Register to track WNX and receive email alerts.
Subject
WNX Ann: Appendix 3Y - EJ

WNX Ann: Application for quotation of securities - WNX

WNX Ann: Proposed issue of securities - WNX

WNX Ann: Strategic Placement & Successful Share Purchase Plan

WNX Article: Distributor Homart Pharma takes stake in Wellnex Life

WNX Ann: Trading Halt

WNX Ann: Pause in Trading

WNX Ann: SPP Update and Investor Briefing

WNX Ann: OneLife Acquires MediPharm Australia and SPP Update

WNX Ann: Trading Update

WNX Ann: Extension of SPP

WNX Ann: Appendix 4G and Corporate Governance Statement

WNX Ann: Annual Report to shareholders

WNX Ann: Investor Presentation

WNX Ann: Share Purchase Plan Cleansing Notice

WNX Ann: SPP Offer Open and Trading Update

WNX Ann: Share Purchase Plan Booklet

WNX Ann: Proposed issue of securities - WNX

WNX Ann: Wellnex Life Launches SPP

WNX Ann: Wellnex Life Acquires Teeth Whitening Brand Mr Bright

WNX Ann: Trading Update

WNX Ann: Wellnex Releases Appendix 4E and Preliminary Results

WNX Ann: Preliminary Final Report

WNX Ann: Change in substantial holding

WNX Ann: Change in substantial holding

WNX Ann: Appendix 4C and Quarterly Report for June 2022 Quarter

WNX Ann: Change in substantial holding

WNX Ann: Wellnex Life forms Joint Venture with OneLife Botanicals

WNX Ann: Trading Update

WNX Ann: Notification of cessation of securities - WNX

WNX Ann: Notification regarding unquoted securities - WNX

WNX Ann: Successful Completion of $6.2m Capital Raising via CN

WNX Ann: Wellnex Life to raise $7.5 million via Convertible Note

WNX Ann: Appendix 4C and Quarterly Report for March 2022 Quarter

WNX Ann: Company Update

WNX Ann: Appendix 3Y - Zack Bozinovski

WNX Ann: Appendix 3Y - George Karafotias

WNX Ann: Change in substantial holding

WNX Ann: Change in substantial holding

WNX Ann: Appendix 3Y - Kobe Li

WNX Ann: Appendix 3Y - George Karafotias

WNX Ann: Appendix 3Y - Zack Bozinovski

WNX Ann: Notification regarding unquoted securities - WNX

WNX Ann: Wellnex Life Signs Supple Agreement with GSK

WNX Ann: Investor Presentation

WNX Ann: Trading Halt

WNX Ann: Wellnex Life Releases Half Year Report

WNX Ann: Half Yearly Report and Accounts

WNX Ann: AHF: JV with WNX to Launch Organic A2 Infant Formula Range

WNX Ann: JV with AHF to Launch Organic A2 Infant Formula Range

Register to track WNX and receive email alerts.